These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 32553187)

  • 1. Seroconversion in household members of COVID-19 outpatients.
    Cox RJ; Brokstad KA; Krammer F; Langeland N;
    Lancet Infect Dis; 2021 Feb; 21(2):168. PubMed ID: 32553187
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France.
    Gallais F; Velay A; Nazon C; Wendling MJ; Partisani M; Sibilia J; Candon S; Fafi-Kremer S
    Emerg Infect Dis; 2021 Jan; 27(1):113-21. PubMed ID: 33261718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19.
    Yamamoto S; Saito M; Nagai E; Toriuchi K; Nagai H; Yotsuyanagi H; Nakagama Y; Kido Y; Adachi E
    J Med Virol; 2021 Feb; 93(2):692-694. PubMed ID: 32897566
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19.
    Shang Y; Liu T; Li J; Wang X; Zhou F
    J Med Virol; 2021 Feb; 93(2):612-614. PubMed ID: 33289107
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
    Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)].
    Herrmann BL
    MMW Fortschr Med; 2020 Aug; 162(14):44-46. PubMed ID: 32780376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
    Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
    Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
    J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in an Obstetric Patient With Antibody Seroconversion.
    Molina LP; Chow SK; Nickel A; Love JE
    Obstet Gynecol; 2020 Oct; 136(4):838-841. PubMed ID: 32701763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays.
    Wolff F; Dahma H; Duterme C; Van den Wijngaert S; Vandenberg O; Cotton F; Montesinos I
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115140. PubMed ID: 32829098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What to Expect from Antibody Assays of SARS-CoV-2?
    Yi X; Cao J
    J Appl Lab Med; 2020 Sep; 5(5):1126-1130. PubMed ID: 32589736
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit.
    Hains DS; Schwaderer AL; Carroll AE; Starr MC; Wilson AC; Amanat F; Krammer F
    JAMA; 2020 Jun; 323(23):2424-2425. PubMed ID: 32407440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of anti-SARS-CoV-2 antibodies in outpatients of a large public university hospital in Sao Paulo, Brazil.
    Oliveira LMDS; Tiyo BT; Silva LTD; Fonseca LAM; Rocha RC; Santos VAD; Ceneviva C; Bedin AA; Almeida A; Duarte AJDS; Oshiro TM
    Rev Inst Med Trop Sao Paulo; 2020; 62():e91. PubMed ID: 33206865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
    den Hartog G; Schepp RM; Kuijer M; GeurtsvanKessel C; van Beek J; Rots N; Koopmans MPG; van der Klis FRM; van Binnendijk RS
    J Infect Dis; 2020 Oct; 222(9):1452-1461. PubMed ID: 32766833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis.
    Liu W; Kou G; Dong Y; Zheng Y; Ding Y; Ni W; Wu W; Tang S; Xiong Z; Zhang Y; Liu L; Zheng S
    J Clin Virol; 2020 Sep; 130():104576. PubMed ID: 32763810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset.
    Lou B; Li TD; Zheng SF; Su YY; Li ZY; Liu W; Yu F; Ge SX; Zou QD; Yuan Q; Lin S; Hong CM; Yao XY; Zhang XJ; Wu DH; Zhou GL; Hou WH; Li TT; Zhang YL; Zhang SY; Fan J; Zhang J; Xia NS; Chen Y
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32430429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure and seroconversion to severe acute respiratory syndrome coronavirus 2 among obstetrical healthcare providers following a contained outbreak.
    Kiefer MK; McKiever ME; Russo JR; Ma'ayeh M; Gee SE; Smith DD; Kniss DA; Cackovic M; Costantine MM; Landon MB; Rood KM
    Am J Obstet Gynecol; 2020 Oct; 223(4):601-603.e2. PubMed ID: 32553914
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2.
    Tollånes MC; Bakken Kran AM; Abildsnes E; Jenum PA; Breivik AC; Sandberg S
    Clin Chem Lab Med; 2020 Aug; 58(9):1595-1600. PubMed ID: 32598303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroconversion in Newly Diagnosed Cases of Coronavirus Disease.
    Chughtai OR; Batool H; Khan MD; Ashraf S
    J Coll Physicians Surg Pak; 2020 Aug; 30(8):801-804. PubMed ID: 32893789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.